EICHOR
● Active Not Recruiting
Evaluation of VX-121/Tezacaftor/Deutivacaftor in Cystic Fibrosis (CF) Participants 1 Through 11 Years of Age
Condition: Cystic Fibrosis · Sponsor: Vertex Pharmaceuticals Incorporated
About this study
The purpose of this study is to evaluate the pharmacokinetics, safety, tolerability and efficacy of VX-121/tezacaftor/deutivacaftor (VX-121/TEZ/D-IVA) in CF participants with at least 1 triple combination responsive (TCR) mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (38)
| Children's Hospital of Orange County | Orange, California, United States | — |
| Stanford University Clinical and Translational Research Unit | Palo Alto, California, United States | — |
| Children's Hospital of Colorado | Aurora, Colorado, United States | — |
| The Emory Clinic / Children's Healthcare of Atlanta at Egleston | Atlanta, Georgia, United States | — |
| Ann & Robert H. Lurie Children's Hospital of Chicago | Chicago, Illinois, United States | — |
| Riley Hospital for Children at Indiana University Health | Indianapolis, Indiana, United States | — |
| Boston Children's Hospital | Boston, Massachusetts, United States | — |
| Children's Respiratory and Critical Care Specialists, P.A., Children's Hospitals and Clinics of Minnesota | Minneapolis, Minnesota, United States | — |
| The Children's Mercy Hospital | Kansas City, Missouri, United States | — |
| Washington University School of Medicine / St. Louis Children's Hospital | St Louis, Missouri, United States | — |
| Cohen Children's Medical Center | Lake Success, New York, United States | — |
| Cincinnati Children's Hospital Medical Center | Cincinnati, Ohio, United States | — |
+ 26 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.